Barclays PLC Avid Bioservices, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Barclays PLC holds 134,598 shares of CDMO stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,598

Previous 134,598 -0.0%

Holding current value

$1.68 Million

Previous $1.53 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$6.7 - $12.45 $446,575 - $829,829	66,653 Added 98.1%	134,598 $1.53 Million
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $112,452 - $164,599	-17,737 Reduced 20.7%	67,945 $485,000
Q1 2024 May 15, 2024	SELL	$5.86 - $8.79 $1.12 Million - $1.68 Million	-191,635 Reduced 69.1%	85,682 $574,000
Q4 2023 Feb 15, 2024	BUY	$4.64 - $9.56 $699,275 - $1.44 Million	150,706 Added 119.03%	277,317 $1.8 Million
Q3 2023 Nov 07, 2023	BUY	$9.4 - $14.04 $66,476 - $99,290	7,072 Added 5.92%	126,611 $1.2 Million
Q2 2023 Aug 03, 2023	BUY	$12.96 - $20.93 $435,183 - $702,808	33,579 Added 39.06%	119,539 $1.67 Million
Q1 2023 May 04, 2023	SELL	$13.48 - $18.79 $1.39 Million - $1.93 Million	-102,781 Reduced 54.46%	85,960 $1.61 Million
Q4 2022 Feb 13, 2023	BUY	$12.61 - $18.74 $822,562 - $1.22 Million	65,231 Added 52.81%	188,741 $2.6 Million
Q3 2022 Nov 03, 2022	BUY	$15.33 - $20.36 $1.6 Million - $2.12 Million	104,317 Added 543.52%	123,510 $2.36 Million
Q2 2022 Aug 12, 2022	SELL	$11.63 - $21.55 $351,970 - $652,189	-30,264 Reduced 61.19%	19,193 $293,000
Q1 2022 May 16, 2022	SELL	$16.63 - $27.73 $490,418 - $817,757	-29,490 Reduced 37.35%	49,457 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$20.7 - $34.18 $1.12 Million - $1.84 Million	53,867 Added 214.78%	78,947 $2.3 Million
Q3 2021 Nov 09, 2021	BUY	$19.05 - $28.32 $321,106 - $477,361	16,856 Added 204.96%	25,080 $542,000
Q2 2021 Aug 13, 2021	SELL	$18.93 - $25.65 $897,471 - $1.22 Million	-47,410 Reduced 85.22%	8,224 $210,000
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $444,014 - $815,025	37,438 Added 205.75%	55,634 $1.01 Million
Q4 2020 Feb 11, 2021	SELL	$7.25 - $11.76 $55,846 - $90,587	-7,703 Reduced 29.74%	18,196 $210,000
Q3 2020 Nov 12, 2020	SELL	$6.53 - $8.6 $33,590 - $44,238	-5,144 Reduced 16.57%	25,899 $198,000
Q2 2020 Aug 12, 2020	BUY	$4.11 - $6.78 $50,166 - $82,756	12,206 Added 64.8%	31,043 $204,000
Q1 2020 May 13, 2020	SELL	$3.15 - $7.39 $117,265 - $275,107	-37,227 Reduced 66.4%	18,837 $96,000
Q4 2019 Feb 10, 2020	BUY	$5.01 - $8.16 $141,948 - $231,197	28,333 Added 102.17%	56,064 $430,000
Q3 2019 Nov 14, 2019	SELL	$5.07 - $7.08 $42,608 - $59,500	-8,404 Reduced 23.26%	27,731 $147,000
Q2 2019 Aug 14, 2019	BUY	$3.43 - $5.6 $74,818 - $122,152	21,813 Added 152.3%	36,135 $202,000
Q1 2019 May 15, 2019	BUY	$3.56 - $4.82 $50,594 - $68,501	14,212 Added 12920.0%	14,322 $61,000
Q4 2018 Feb 14, 2019	SELL	$4.04 - $6.75 $76,303 - $127,487	-18,887 Reduced 99.42%	110 $0
Q3 2018 Nov 14, 2018	BUY	$4.28 - $7.32 $65,385 - $111,827	15,277 Added 410.67%	18,997 $130,000
Q2 2018 Aug 14, 2018	BUY	$3.1 - $3.93 $11,532 - $14,619	3,720 New	3,720 $15,000

Others Institutions Holding CDMO

# of Institutions

188

Shares Held

68.4M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account